Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
出版年份 2017 全文链接
标题
Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-07-14
DOI
10.1038/s41598-017-06327-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA
- (2017) Xin Yang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-free DNAs in Blood
- (2017) Jinfeng Zou et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- PIK3CAmutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
- (2016) S. Loibl et al. ANNALS OF ONCOLOGY
- The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival
- (2016) Ines Vasconcelos et al. BREAST
- Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients
- (2016) Firoz Ahmad et al. MEDICAL ONCOLOGY
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
- (2016) Ebubekir Dirican et al. TUMOR BIOLOGY
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
- (2016) Jacob J. Chabon et al. Nature Communications
- Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
- (2016) Ji-Yeon Kim et al. Cancer Research and Treatment
- PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
- (2015) Chiya Oshiro et al. BREAST CANCER RESEARCH AND TREATMENT
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- The influence of subclonal resistance mutations on targeted cancer therapy
- (2015) Michael W. Schmitt et al. Nature Reviews Clinical Oncology
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients
- (2015) Jiaxin Niu et al. OncoTargets and Therapy
- Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
- (2015) Xun Yuan et al. PLoS One
- Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer
- (2014) L. M. Arthur et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks
- (2013) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance
- (2013) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- Signaling Network Assessment of Mutations and Copy Number Variations Predict Breast Cancer Subtype-Specific Drug Targets
- (2013) Naif Zaman et al. Cell Reports
- Analysis of PIK3CA Mutations in Breast Cancer Subtypes
- (2013) Ruza Arsenic et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
- (2012) Nicholas A. Saunders et al. EMBO Molecular Medicine
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer
- (2009) Matthew J. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
- (2009) K. Kalinsky et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started